Lisa Gill
Stock Analyst at JP Morgan
(3.29)
# 1,040
Out of 4,761 analysts
133
Total ratings
49.43%
Success rate
2.31%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Neutral | $257 → $256 | $257.37 | -0.53% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $63.75 | +27.06% | 5 | Feb 18, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $173 → $180 | $171.63 | +4.88% | 2 | Feb 4, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $127.32 | +13.89% | 6 | Feb 4, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $38 → $40 | $32.09 | +24.65% | 3 | Jan 24, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $241.71 | +24.53% | 2 | Jan 24, 2025 | |
| PACS PACS Group | Downgrades: Neutral | $18 | $12.98 | +38.67% | 2 | Dec 17, 2024 | |
| INNV InnovAge Holding | Downgrades: Underweight | $5 | $3.36 | +49.03% | 4 | Dec 17, 2024 | |
| SGRY Surgery Partners | Maintains: Neutral | $38 → $28 | $25.34 | +10.52% | 4 | Dec 3, 2024 | |
| PRVA Privia Health Group | Maintains: Overweight | $27 → $28 | $24.57 | +13.96% | 4 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $10.21 | +46.91% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $11.37 | -20.81% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $6.25 | +188.00% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $596.61 | +10.79% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $303.07 | +44.52% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $29 | $23.16 | +25.22% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.88 | +29.73% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $284.99 | +38.60% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $249.47 | -2.59% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $179.34 | +3.71% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $546 → $559 | $468.81 | +19.24% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $130.53 | +7.26% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $318.00 | +4.40% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $386.58 | +63.23% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.84 | +106.61% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $3.63 | +148.28% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.33 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.63 | +4.92% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $77.03 | +7.75% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $10 | $13.31 | -24.84% | 3 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $57.49 | +70.46% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $24 | $31.07 | -22.74% | 4 | Jun 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.77 | - | 4 | Dec 19, 2017 |
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $257.37
Upside: -0.53%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $63.75
Upside: +27.06%
Quest Diagnostics
Feb 4, 2025
Maintains: Neutral
Price Target: $173 → $180
Current: $171.63
Upside: +4.88%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $127.32
Upside: +13.89%
Option Care Health
Jan 24, 2025
Maintains: Overweight
Price Target: $38 → $40
Current: $32.09
Upside: +24.65%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $241.71
Upside: +24.53%
PACS Group
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $12.98
Upside: +38.67%
InnovAge Holding
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.36
Upside: +49.03%
Surgery Partners
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $25.34
Upside: +10.52%
Privia Health Group
Nov 29, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $24.57
Upside: +13.96%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $10.21
Upside: +46.91%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $11.37
Upside: -20.81%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $6.25
Upside: +188.00%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $596.61
Upside: +10.79%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $303.07
Upside: +44.52%
Aug 19, 2024
Initiates: Overweight
Price Target: $29
Current: $23.16
Upside: +25.22%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.88
Upside: +29.73%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $284.99
Upside: +38.60%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $249.47
Upside: -2.59%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $179.34
Upside: +3.71%
May 30, 2024
Maintains: Overweight
Price Target: $546 → $559
Current: $468.81
Upside: +19.24%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $130.53
Upside: +7.26%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $318.00
Upside: +4.40%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $386.58
Upside: +63.23%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.84
Upside: +106.61%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $3.63
Upside: +148.28%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.33
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.63
Upside: +4.92%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $77.03
Upside: +7.75%
Jul 7, 2023
Maintains: Neutral
Price Target: $12 → $10
Current: $13.31
Upside: -24.84%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $57.49
Upside: +70.46%
Jun 7, 2018
Maintains: Underweight
Price Target: $26 → $24
Current: $31.07
Upside: -22.74%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $18.77
Upside: -